Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being investigated for metabolic applications. This synthetic peptide demonstrates superior efficacy in glucose regulation and weight management compared to single-receptor agonists.
The compound exhibits preferential binding affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique pharmacological profile produces enhanced glycemic control through multiple mechanisms of action. Research indicates tirzepatide effectively mimics native GIP activity while providing the established benefits of GLP-1 receptor activation.
Our facility offers tirzepatide in lyophilized powder form with guaranteed purity exceeding 99.5%. The product undergoes comprehensive analytical testing including mass spectrometry and HPLC analysis to verify identity and purity. Each batch includes complete documentation including Certificate of Analysis.
Available standard sizes include 5mg, 10mg, and 15mg vials, with custom formulations available upon request. We support bulk orders and private label options for research institutions and pharmaceutical developers.
Note: This product is intended for research purposes only. Not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.
